XBiotech Management
Management criteria checks 2/4
XBiotech's CEO is John Simard, appointed in Mar 2005, has a tenure of 19.58 years. total yearly compensation is $5.56M, comprised of 19.2% salary and 80.8% bonuses, including company stock and options. directly owns 12.55% of the company’s shares, worth €24.56M. The average tenure of the management team and the board of directors is 6.9 years and 7.5 years respectively.
Key information
John Simard
Chief executive officer
US$5.6m
Total compensation
| CEO salary percentage | 19.2% |
| CEO tenure | 19.6yrs |
| CEO ownership | 12.6% |
| Management average tenure | 6.9yrs |
| Board average tenure | 7.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$35m |
| Mar 31 2024 | n/a | n/a | -US$31m |
| Dec 31 2023 | US$6m | US$1m | -US$25m |
| Sep 30 2023 | n/a | n/a | -US$23m |
| Jun 30 2023 | n/a | n/a | -US$28m |
| Mar 31 2023 | n/a | n/a | -US$31m |
| Dec 31 2022 | US$5m | US$881k | -US$33m |
| Sep 30 2022 | n/a | n/a | -US$36m |
| Jun 30 2022 | n/a | n/a | -US$27m |
| Mar 31 2022 | n/a | n/a | -US$20m |
| Dec 31 2021 | US$8m | US$777k | -US$17m |
| Sep 30 2021 | n/a | n/a | -US$13m |
| Jun 30 2021 | n/a | n/a | -US$12m |
| Mar 31 2021 | n/a | n/a | -US$14m |
| Dec 31 2020 | US$3m | US$684k | -US$11m |
| Sep 30 2020 | n/a | n/a | US$677m |
| Jun 30 2020 | n/a | n/a | US$673m |
| Mar 31 2020 | n/a | n/a | US$674m |
| Dec 31 2019 | US$11m | US$591k | US$669m |
| Sep 30 2019 | n/a | n/a | -US$24m |
| Jun 30 2019 | n/a | n/a | -US$23m |
| Mar 31 2019 | n/a | n/a | -US$23m |
| Dec 31 2018 | US$1m | US$585k | -US$21m |
| Sep 30 2018 | n/a | n/a | -US$22m |
| Jun 30 2018 | n/a | n/a | -US$23m |
| Mar 31 2018 | n/a | n/a | -US$27m |
| Dec 31 2017 | US$702k | US$566k | -US$33m |
Compensation vs Market: John's total compensation ($USD5.56M) is above average for companies of similar size in the German market ($USD808.43K).
Compensation vs Earnings: John's compensation has increased whilst the company is unprofitable.
CEO
John Simard (62 yo)
19.6yrs
Tenure
US$5,556,481
Compensation
Mr. John Simard is the Founder of XBiotech, Inc. and serves as its Chairman and has been its Chief Executive Officer and President since March 2005. Mr. Simard serves as the Chairman, Chief Executive Offic...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 19.6yrs | US$5.56m | 12.55% $ 24.6m | |
| Director of Finance | 1.7yrs | US$279.29k | 0.084% $ 163.8k | |
| Chief Scientific Officer | 6.9yrs | US$720.50k | 0% $ 0 |
6.9yrs
Average Tenure
46yo
Average Age
Experienced Management: 4XB's management team is seasoned and experienced (6.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 19.6yrs | US$5.56m | 12.55% $ 24.6m | |
| Independent Director | 15.7yrs | US$190.94k | 8.66% $ 16.9m | |
| Independent Director | 6.6yrs | US$187.94k | 0.033% $ 64.2k | |
| Member of Scientific Advisory Board & Independent Director | 6.1yrs | US$163.94k | 0.082% $ 160.6k | |
| Member of Scientific Advisory Board | 6.1yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.5yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.5yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.5yrs | no data | no data | |
| Lead Independent Director | 6.7yrs | US$196.94k | 0.66% $ 1.3m | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
7.5yrs
Average Tenure
75yo
Average Age
Experienced Board: 4XB's board of directors are considered experienced (7.5 years average tenure).